2 When compared to traditional blood glucose monitoring, using a flash glucose monitor can improve the ability of an individual living with type 1 or type 2 diabetes to monitor and manage their chronic condition along with their healthcare team, which is key to better diabetes management and health outcomes. It has impactful real-world 2 and clinical research, 3,4, 5, 6 showing how the FreeStyle Libre system is associated with better glucose control 7, decreased time in hypoglycemia 3, 4, 5, 6 and hyperglycemia 3, 4 more time in optimal glucose range, 7 and improved HbA1C. No routine confirmatory finger pricks are required for treatment decisions, even when glucose is low, falling or rapidly changing. "Reimbursement of the FreeStyle Libre 2 system in Quebec is an important step toward helping more people with diabetes get access and we continue to work with all provincial governments to improve access for all people with diabetes across Canada."Ībbott's FreeStyle Libre 2 system has outstanding accuracy 1. "The best healthcare solution is the one that helps the most people, which is why we designed our FreeStyle Libre portfolio with access and affordability in mind from the very beginning," said Philippe Busque, general manager of Abbott's diabetes care business in Canada. Users can also share data with their family members via the LibreLinkUp mobile app.
ABBOTT LABS FREESTYLE LIBRE FLASH GLUCOSE MONITORING SYSTEM BLUETOOTH
Using Bluetooth technology, the FreeStyle Libre 2 system can automatically π alert users when their glucose is too high or low without needing to scan the sensor. With a one-second scan of a smartphone using the FreeStyle Libre 2 app, α users can see their glucose reading, trend arrow and eight-hour history. It measures glucose every minute to help people living with diabetes and their healthcare team make informed treatment decisions. The sensor, which is the size of a Canadian Toonie, is worn on the back of the upper arm for up to 14 days.
The FreeStyle Libre 2 system represents a significant advancement in diabetes management for Canadians. Quebec was one of the first Canadian provinces to reimburse flash glucose monitoring technology and with the addition of FreeStyle Libre 2, families with children who are living with diabetes will have the opportunity to benefit from this important diabetes management tool. 16, 2022 /CNW/ - Abbott today announced that its FreeStyle Libre 2 flash glucose monitoring system * is now reimbursed under the Régie de l'assurance maladie du Quebec (RAMQ) for Quebec residents aged four and over who manage their diabetes (type 1 or type 2) with multiple daily injections of insulin ~. With a simple scan, the innovative FreeStyle Libre 2 delivers accurate, real-time glucose readings and alerts users when their glucose is too high or too low, without the need for routine finger pricks∞ The addition of the FreeStyle Libre 2 system enables access for Quebec residents aged four and over who manage their diabetes (type 1 or type 2) with multiple daily injections of insulin Quebec joins Ontario and Prince Edward Island in offering access to both FreeStyle Libre and FreeStyle Libre 2 flash glucose monitoring technology
0 kommentar(er)
